维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="GHAHRAMANI P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Aspirin for primary prevention of coronary heart diseasc: safety and absolute benefit related to coronary risk derived from meta - analysis of randomised trials 显示文摘	Sanmuganathan PS Ghahramani P Jackson PR	2001	Heart2001，85，3：	1
2	Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of ran- domised trials 显示文摘	Sanmuganathan PS Ghahramani P Jackson PR	2001	Heart2001，85，3：	1
3	Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens显示文摘	Purkins L Wood N Ghahramani P		0，，08：	1
4	Panic disorder, anxiety and depression in resistant hypertension-a case-control study显示文摘	Davies SJ Ghahramani P Jackson PR	1997	J Hypertens1997，15，：	1
5	Association of panic disorder and panic attacks with hypertension 显示文摘	Davies SJ Ghahramani P Jackson PR	1999	Am J Med1999，107，：	1
6	Association of panic disorder and panic attacks with hypertension显示文摘	Davies S J Ghahramani P Jackson PR	1999	Am J Med1999，107，4：	1
7	In- fluence of genetic polymorphisms in the 2-adrenoceptor on desensitisation in human lung mast cells显示文摘	CHONG L K CHOWDRY J GHAHRAMANI P	2000	Pharmacoge- netics2000，10，：	1
8	Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens显示文摘	Purkins L Wood N Ghahramani P	2002	Agents Chemother2002，46，8：	1
9	Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials显示文摘	Sanmuganathan PS Ghahramani P Jackson PR Wallis EJ Ramsay LE	2001	Heart2001，85，3：	1
10	Phammcokinetics and safety of voriconazole following intravenousto oral-dose escalation regimens显示文摘	Punkins L Wood N Ghahramani P	2002	Antimicrob Agents Chemother2002，46，8：	1
11	Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens 显示文摘	Purkins L Wood N Ghahramani P	2002	Antimicrob Agents Chemother2002，46，8：	1
12	Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomized trials显示文摘	Sanmuganathan PS Ghahramani P Jackson PR	2001	Heart2001，85，：	1
13	Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration 显示文摘	Purkins L Wood N Ghahramani P	2003	Br J Clin Pharmacol2003，56，1：	1
14	Pharmacoki- netics and safety of voriconazole following intravenous- to oral-dose escalation regimens显示文摘	Purkins L Wood N Ghahramani P	2002	Antimicrob Agents Chemother2002，46，8：	1
15	No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers 显示文摘	Purkins L Wood N Ghahramani P	2003	Br J Clin Pharmacol2003，56，1：	1
16	Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration 显示文摘	PURKINS L WOOD N GHAHRAMANI P	2003	Br J Clin Pharmacol2003，561，：	1
17	Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens显示文摘	Purkins L Wood N Ghahramani P	2002	Antimicrob Agents Chemother2002，46，：	1
18	Pharmacokinetics and safety of voriconazole following intravenous -to oral-dose escalation regimens显示文摘	Purkins L Wood N Ghahramani P	2002	Antimicrobial Agents and Chemotherapy2002，46，8：	1
19	No clinically signifi- cant effect of erythromycin or azithromycin on the pharmacoki- netics of voriconazole in healthy male volunteers显示文摘	Purkins L Wood N Ghahramani P	2003	Br J Clin Pharmacol2003，561，：	1
20	Pharmacokinetics and safety of voriconazole following intravenousto oral-dose escalation regimens显示文摘	Purkins L Wood N Ghahramani P	2002	Antimicrob A- gents Chemother2002，46，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示